The viability of news reporting these days has taken a hit and people confined to their homes are making it worse. Most are aware that one of the most read news items is a vaccine and how human trials are progressing. One person who underwent it is Dr. Elisa Granato, a microbiologist at the University of Oxford. Contrary to unverified reports that she died after being injected with a trial vaccine, the 32-year-old is well and good.
There was an online article that alleged that Granato had died due to complications when she took the vaccine. It was initially downplayed by the government, although most wanted further proof. That came in the form of her coming out in the open to show everyone that she is well and good. Granato took the vaccine on her 32nd birthday last Apr. 23, BBC reported.
“Nothing like waking up to a fake article on your death … I’m doing fine everyone,” Granato wrote in a private tweet. Knowing she had to do something not so hard to put a stop to vicious rumors meant nothing more for click-bait, Granato explained to BBC news why she took the vaccine and how it would be her own easy and simple way to put a stop to the nonsense via Skype interview.
“I’m a scientist, so I wanted to try to support the scientific process wherever I can,” Granato said. “Since I don’t study viruses, I felt a bit useless these days, so I felt like this is a very easy way for me to support the cause.”
It was claimed by the online article that Granato suffered complications and had preexisting medical conditions. It alleged that she died hours after having the injection. Aside from Granato’s tweet, a spokesperson for the Department of Health and Social Care also posted on social media debunking the claim.
“News circulating on social media that the first volunteer in a UK coronavirus vaccine trial has died is completely untrue,” the statement read.
Of the people picked for the human trial, only half will receive the COVID-19 vaccine. The other half will get a controlled vaccine that protects against meningitis and not the coronavirus. Patients will not be informed about what vaccine they will be getting. Only the ones carrying out to inject the vaccine will be aware.
Sarah Gilbert, professor of vaccinology at the Jenner Institute, led the pre-trial research. She is 80 percent confident that the vaccine will be effective.
“Personally I have a high degree of confidence in this vaccine,” she said. “Of course, we have to test it and get data from humans. We have to demonstrate it actually works and stops people getting infected with coronavirus before using the vaccine in the wider population.”